Predicate |
Object |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2500-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2430-02 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-3834 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0663 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-3847 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-3895 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-28 |
filingDate |
2010-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2016-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2016-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CN-102971414-B |
titleOfInvention |
The treatment of fracture |
abstract |
The mescenchymal stem cell cultivated when there is HS-2 is used for the treatment of the purposes of fracture.Compared with using the fractures of the mesenchymal cell cultivated without HS-2, the fracture repair of these cells is used to be strengthened.These mescenchymal stem cells can be formulated in pharmaceutical composition and to be injected directly into fracture tissue around or to use in biocompatible implant or prosthese. |
priorityDate |
2009-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |